Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVERS.L Regulatory News (VERS)

  • There is currently no data for VERS

Additional Listing & Total Voting Rights

27 Oct 2016 08:41

RNS Number : 6150N
Verseon Corporation
27 October 2016
 

27 October 2016

 

Verseon Corporation

 

("Verseon" or the "Company")

 

Additional Listing & Total Voting Rights

 

Verseon, a technology-based pharmaceutical company, announces that on 25 October 2016, Mr. Grover Wickersham, Non-Executive Director of the Company, has been issued a grant of restricted stock units ("RSUs") that relate to payment of his Director's fees in the form of restricted stock. Mr. Wickersham's restricted stock grant totals 15,463 Common Shares and is calculated by reference to the closing price on 25 October 2016 of the Company's common shares in USD, being $1.94. The RSUs vest quarterly in equal proportions over a 6 month period starting from 30 October 2016.

 

For further information please contact:

 

Verseon Corporation

+1 (510) 225 9000

Arthur Shmurun / Amy Thai

Cenkos Securities (NOMAD and Broker)

+44 (0) 20 7397 8900

Mark Connelly / Steve Cox

Buchanan Communications Ltd (PR Advisers)

+44 (0) 20 7466 5000

Henry Harrison-Topham / Sophie Cowles

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Mr Grover Wickersham

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Verseon Corporation

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Restricted stock grant of Common Shares of par value $0.001

 

ISIN: USU9221J1098

 

 

b)

 

Nature of the transaction

 

 

Issuance of restricted stock units

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

$1.94

15,463

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

15,463

 

 

$1.94

e)

 

Date of the transaction

 

 

25 October 2016

f)

 

Place of the transaction

 

 

N/a

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXEXADNKFEF
Date   Source Headline
27th Oct 20168:41 amRNSAdditional Listing & Total Voting Rights
21st Sep 20167:00 amRNSDirector/PDMR Shareholding
12th Sep 20167:00 amRNSAdditional Listing & Total Voting Rights
8th Sep 20167:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Sep 20167:00 amRNSInterim Results
9th Aug 201611:40 amRNSAdditional Listing & Total Voting Rights
22nd Jun 20167:00 amRNSAdditional Listing & Total Voting Rights
6th Jun 20167:00 amRNSVerseon to Present Latest Anticoagulant Results
27th Apr 20167:00 amRNSAdditional Listing & Total Voting Rights
21st Apr 20167:00 amRNSResult of AGM
7th Apr 20167:00 amRNSNotice of AGM
6th Apr 20167:00 amRNSTR-1: Notification of Major Interest in Shares
4th Apr 20167:00 amRNSVerseon to present additional results at BioEurope
21st Mar 20167:00 amRNSHoldings in Company
17th Mar 20167:00 amRNSAdditional Listing & Total Voting Rights
7th Mar 20167:00 amRNSFinal Results
1st Mar 20167:00 amRNSAdditional Listing & Total Voting Rights
29th Feb 20167:00 amRNSVerseon presents low bleeding risk anticoagulants
10th Feb 20167:00 amRNSVerseon to present new preclinical results at ICHB
4th Feb 20167:00 amRNSAdditional Listing & Total Voting Rights
12th Jan 20167:00 amRNSVerseon to Present Data
29th Dec 201510:15 amRNSAdditional Listing & Total Voting Rights
29th Oct 20157:00 amRNSAdditional Listing & Total Voting Rights
25th Sep 20157:00 amRNSAdditional Listing & Total Voting Rights
17th Sep 20157:00 amRNSTR-1: Notification of Major Interest in Shares
15th Sep 20157:00 amRNSTR-1: Notification of Major Interest in Shares
7th Sep 20157:00 amRNSInterim Results
28th Aug 20159:34 amRNSDepository Interest Programme
20th Aug 20158:55 amRNSVerseon Acquires R&D Facility
19th Aug 20159:09 amRNSAdditional Listing & Total Voting Rights
22nd Jul 20158:39 amRNSAdditional Listing & Total Voting Rights
29th Jun 20158:58 amRNSAnnual Report Announcement
25th Jun 20159:57 amRNSHolding(s) in Company
17th Jun 20157:00 amRNSAdditional Listing & Total Voting Rights
7th May 20158:12 amRNSAIM Admission - First day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.